Details for 2011162667

Up to date per 01.04.2026

Actions

Title / Product Name

Verfahren und Zusammensetzungen zur Behandlung persistenter Infektionen mittels Hemmung des programmierten 1 (PD-1)-Zelltodweges

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2011162667

EP Publication Number

2397155

E-Number

953751

Language

PCT Number

Publication Date

21.12.2011 A

13.12.2017 B1

Registration Date

13.12.2017

AT Publication Date

15.12.2017

Application Date

08.06.2006

Registration Number

Priorities

08.06.2005

688872 P

IPC

A61K 39/00 20060101AFI20170619BHEP

Maximum Duration of Protection

08.06.2026

Owner

Dana-Farber Cancer Institute, Inc.450 Brookline Avenue Boston, MA 02215US

The Brigham and Women's Hospital, Inc.75 Francis Street Boston, MA 02115US

Emory University1599 Clifton Road NE 4th Floor Atlanta, GA 30322US

President and Fellows of Harvard College17 Quincy Street Cambridge, MA 02138US

Representative

No representatives present

Inventor

Freeman, Gordan305 Walnut Street Brookline, MA 02445US

Sharpe, Arlene305 Walnut Street Brookline, MA 02445US

Dorfman, David M.42 Welland Road Brookline, MA 02445US

Ahmed, Rafi1811 Durand Mill Drive Atlanta, GA 30307US

Barber, Daniel5440 Marinelli Road, Apt. 206 North Bethesda, MD 20852US

Wherry, E. John110 Myrtie Avenue Havertown, Pennsylvania 19083US